- Home
- / Xenetic Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Xenetic Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.7
2024-10-29
Market Capitalization
$5.7 M
2024-10-29
Revenue
$3 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 112.8K | 1.0M | 3.0M | 7.6M | 17.1K | 436.9K | 1.2M | 1.7M | 2.5M | 2.5M | 3.0M | |||
| General and administrative expense | 6.6M | 6.6M | 3.6M | 3.4M | ||||||||||
| Operating expense total | 9.6M | 12.9M | 8.6M | |||||||||||
| EBIT | (116.7K) | (8.6M) | (12.9M) | (9.8M) | (47.4M) | (3.6M) | (7.3M) | (12.9M) | (13.9M) | (5.7M) | (6.7M) | (4.5M) | (4.2M) | (2.8M) |
| EBIT margin, % | -103.4% | -861.3% | -1581.0% | -47.1% | -75511.7% | -3189.8% | -393.6% | -168.2% | -95.2% | |||||
| Interest income | 34.9K | 19.0K | 1.7K | 32.0 | 16.5K | |||||||||
| Interest expense | 13.0K | 4.7K | 2.7M | 6.8M | 26.4K | 509.0 | 108.5K | 126.2K | 100.5K | 167.2K | 355.8K | 249.9K | 148.0K | |
| Pre tax profit | (8.6M) | (14.3M) | ||||||||||||
| Income tax expense | (2.9M) | |||||||||||||
| Net Income | (129.7K) | (8.6M) | (14.3M) | (12.5M) | (54.2M) | (3.6M) | (7.3M) | (12.8M) | (10.9M) | (5.6M) | (6.6M) | (4.1M) | (4.0M) | (2.7M) |
| EPS | (0.5) | (2.0) | (2.6) | (1.6) |